-
1
-
-
33750519754
-
Antimicrobial agents: Antibacterials and antifungals
-
Washington DC: ASM Press.
-
Bryskier A. 2005. Antimicrobial agents: Antibacterials and antifungals. Washington DC: ASM Press, pp 1288-1719.
-
(2005)
, pp. 1288-1719
-
-
Bryskier, A.1
-
2
-
-
0023752762
-
Treatment of systemic fungal infections: Recent progress and current problems
-
Walsh TJ, Pezzo A. 1998. Treatment of systemic fungal infections: Recent progress and current problems. Eur J Clin Microbiol Infect Dis 7:460-475.
-
(1998)
Eur J Clin Microbiol Infect Dis
, vol.7
, pp. 460-475
-
-
Walsh, T.1
Pezzo, A.2
-
3
-
-
0025280829
-
Amphotericin B: Still the 'gold standard' for antifungal therapy
-
155-161, 165-166.
-
Sarosi GA. 1990. Amphotericin B: Still the 'gold standard' for antifungal therapy. Postgrad Med 88:151-152, 155-161, 165-166.
-
(1990)
Postgrad Med
, vol.88
, pp. 151-152
-
-
Sarosi, G.1
-
4
-
-
0025241257
-
Antifungal and surgical treatment of invasive fungal aspergillosis: Review of 2121 published cases
-
Denning DW, Stevens DA. 1990. Antifungal and surgical treatment of invasive fungal aspergillosis: Review of 2121 published cases. Rev Infect Dis 12:1147-1201.
-
(1990)
Rev Infect Dis
, vol.12
, pp. 1147-1201
-
-
Denning, D.1
Stevens, D.2
-
5
-
-
0023926807
-
A stability study of amphotericin B in aqueous media using factorial design
-
Hung CT, Lam FC, Perrier DG, Souter A. 1988. A stability study of amphotericin B in aqueous media using factorial design. Int J Pharm 44:117-123.
-
(1988)
Int J Pharm
, vol.44
, pp. 117-123
-
-
Hung, C.1
Lam, F.2
Perrier, D.3
Souter, A.4
-
6
-
-
0042383358
-
Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nanosphere
-
Fukui H, Koike T, Saheki A, Sonoke S, Tomii Y, Seki J. 2003. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nanosphere. Int J Pharm 263:51-60.
-
(2003)
Int J Pharm
, vol.263
, pp. 51-60
-
-
Fukui, H.1
Koike, T.2
Saheki, A.3
Sonoke, S.4
Tomii, Y.5
Seki, J.6
-
7
-
-
33947148730
-
Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form
-
Baas B, Kindt K, Scott A, Scott J, Mikulecky P, Hartsel SC. 1999. Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form. AAPS PharmSci 1:1-11.
-
(1999)
AAPS PharmSci
, vol.1
, pp. 1-11
-
-
Baas, B.1
Kindt, K.2
Scott, A.3
Scott, J.4
Mikulecky, P.5
Hartsel, S.6
-
8
-
-
21444453616
-
Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary Aspergillosis
-
Gavaldà J, Martín MT, López P, Gomis X, Ramírez JL, Rodríguez D, Len O, Puigfel Y, Ruíz I, Pahissa A. 2005. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary Aspergillosis. Antimicrob Agents Chemother 49:3028-3030.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 3028-3030
-
-
Gavaldà, J.1
Martín, M.2
López, P.3
Gomis, X.4
Ramírez, J.5
Rodríguez, D.6
Len, O.7
Puigfel, Y.8
Ruíz, I.9
Pahissa, A.10
-
9
-
-
34247596598
-
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: A retrospective study
-
Lowry CM, Marty FM, Vargas SO, Lee JT, Fiumara K, Deykin A, Baden LR. 2007. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: A retrospective study. Transplant Infect Dis 9:121-125.
-
(2007)
Transplant Infect Dis
, vol.9
, pp. 121-125
-
-
Lowry, C.1
Marty, F.2
Vargas, S.3
Lee, J.4
Fiumara, K.5
Deykin, A.6
Baden, L.7
-
10
-
-
77950518252
-
Feasibility, tolerability and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
-
Monforte V, Ussetti P, Gavaldà J, Bravo C, Laporta R, Len O, García-Gallo CL, Tenorio L, Solé J, Román A. 2010. Feasibility, tolerability and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. J Heart Lung Transplant 29:523-530.
-
(2010)
J Heart Lung Transplant
, vol.29
, pp. 523-530
-
-
Monforte, V.1
Ussetti, P.2
Gavaldà, J.3
Bravo, C.4
Laporta, R.5
Len, O.6
García-Gallo, C.7
Tenorio, L.8
Solé, J.9
Román, A.10
-
11
-
-
4143052855
-
Development of liposomal amphotericin B dry powder inhaler formulation
-
Shah SP, Misra A. 2004. Development of liposomal amphotericin B dry powder inhaler formulation. Drug Deliv 11:247-253.
-
(2004)
Drug Deliv
, vol.11
, pp. 247-253
-
-
Shah, S.1
Misra, A.2
-
12
-
-
6344240332
-
Supercooled smectic nanoparticles: A potential novel carrier system for poorly water soluble drugs
-
Kuntsche J, Westesen K, Drechsler M, Koch MHJ, Bunjes H. 2004. Supercooled smectic nanoparticles: A potential novel carrier system for poorly water soluble drugs. Pharm Res 21:1834-1843.
-
(2004)
Pharm Res
, vol.21
, pp. 1834-1843
-
-
Kuntsche, J.1
Westesen, K.2
Drechsler, M.3
Koch, M.4
Bunjes, H.5
-
13
-
-
0030248567
-
Development and investigation of a thermo-responsive cholesteryl oleyl carbonate-embedded membrane
-
Lin YY, Chen KS, Lin SY. 1996. Development and investigation of a thermo-responsive cholesteryl oleyl carbonate-embedded membrane. J Control Release 41:163-170.
-
(1996)
J Control Release
, vol.41
, pp. 163-170
-
-
Lin, Y.1
Chen, K.2
Lin, S.3
-
14
-
-
0034329516
-
Effect of skin-penetrating enhancers on the thermophysical properties of cholesteryl oleyl carbonate embedded in a thermo-responsive membrane
-
Lin SY, Li MJ, Lin HL. 2000. Effect of skin-penetrating enhancers on the thermophysical properties of cholesteryl oleyl carbonate embedded in a thermo-responsive membrane. J Mater Sci Med 11:701-704.
-
(2000)
J Mater Sci Med
, vol.11
, pp. 701-704
-
-
Lin, S.1
Li, M.2
Lin, H.3
-
15
-
-
61749103061
-
Thermotropic phase behavior of sodium cholesteryl carbonate
-
Chuealee R, Wiedmann TS, Srichana T. 2009. Thermotropic phase behavior of sodium cholesteryl carbonate. J Mater Res 24:156-163.
-
(2009)
J Mater Res
, vol.24
, pp. 156-163
-
-
Chuealee, R.1
Wiedmann, T.2
Srichana, T.3
-
16
-
-
0034932234
-
Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles
-
Tiyaboonchai W, Woiszwillo J, Middaugh RC. 2001. Formulation and characterization of amphotericin B-polyethylenimine-dextran sulfate nanoparticles. J Pharm Sci 90:902-914.
-
(2001)
J Pharm Sci
, vol.90
, pp. 902-914
-
-
Tiyaboonchai, W.1
Woiszwillo, J.2
Middaugh, R.3
-
17
-
-
85056421112
-
Surfactants and polymers in drug delivery
-
New York: Marcel Dekker, Inc.
-
Malmsten M. 2002. Surfactants and polymers in drug delivery. New York: Marcel Dekker, Inc, pp 19-25.
-
(2002)
, pp. 19-25
-
-
Malmsten, M.1
-
18
-
-
79952216014
-
Antibiotics in laboratory medicine
-
In; Lorian V, Ed. 5th ed. Baltimore: Lippincott Williams & Wilkins.
-
Pfaller M A. Diekema DJ, Rinaldi MG. 1996. Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids. In Antibiotics in laboratory medicine; Lorian V, Ed. 5th ed. Baltimore: Lippincott Williams & Wilkins, pp 226-265.
-
(1996)
Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids
, pp. 226-265
-
-
Pfaller, M.A.1
Diekema, D.2
Rinaldi, M.3
-
19
-
-
0037331321
-
Application of spectrofluorometry for evaluation of dry powder inhalers in vitro
-
Srichana T, Suedee R, Srisudjai P. 2003. Application of spectrofluorometry for evaluation of dry powder inhalers in vitro. Pharmazie 58:125-129.
-
(2003)
Pharmazie
, vol.58
, pp. 125-129
-
-
Srichana, T.1
Suedee, R.2
Srisudjai, P.3
-
20
-
-
0032102794
-
On the relationship between drug and carrier deposition from dry powder inhalers in vitro
-
Srichana T, Martin GP, Marriott C. 1998. On the relationship between drug and carrier deposition from dry powder inhalers in vitro. Int J Pharm 167:13-23.
-
(1998)
Int J Pharm
, vol.167
, pp. 13-23
-
-
Srichana, T.1
Martin, G.2
Marriott, C.3
-
21
-
-
0035834246
-
Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide) by solvent evaporation method: Effect on the solubilization and haemolytic activity of amphotericin B
-
Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide) by solvent evaporation method: Effect on the solubilization and haemolytic activity of amphotericin B. J Control Release 77:155-160.
-
J Control Release
, vol.77
, pp. 155-160
-
-
Lavasanifar, A.1
Samuel, J.2
Kwon, G.3
-
22
-
-
0034532061
-
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents
-
Aller AI, Martín-Mazuelos E, Gutiérrez MJ, Bernal S, Chávez M, Recio FJ. 2000. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents. J Antimicrob Chemother 46:997-1000.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 997-1000
-
-
Aller, A.1
Martín-Mazuelos, E.2
Gutiérrez, M.3
Bernal, S.4
Chávez, M.5
Recio, F.6
-
23
-
-
17144459616
-
In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method
-
López-Jodra O, Torres-Rodríguez JM, Méndez-Vásquez R, Ribas-Forcadell E, Morera-López Y, Baró-Tomás T, Alia-Aponte C. 2000. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J Antimicrob Chemother 45:645-649.
-
(2000)
J Antimicrob Chemother
, vol.45
, pp. 645-649
-
-
López-Jodra, O.1
Torres-Rodríguez, J.2
Méndez-Vásquez, R.3
Ribas-Forcadell, E.4
Morera-López, Y.5
Baró-Tomás, T.6
Alia-Aponte, C.7
-
24
-
-
0029878917
-
Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test
-
Van Eldere J, Joosten L, Verhaeghe V, Surmont I. 1996. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test. J Clin Microbiol 34:842-847.
-
(1996)
J Clin Microbiol
, vol.34
, pp. 842-847
-
-
Van Eldere, J.1
Joosten, L.2
Verhaeghe, V.3
Surmont, I.4
-
25
-
-
33645777826
-
Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome
-
Park BJ, Arthington-Skaggs BA, Hajjeh RA, Iqbal N, Ciblak MA, Lee-Yang W, Hairston MD, Phelan M, Plikaytis BD, Sofair AN, Harrison LH, Fridkin SK, Warnock DW. 2006. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother 50:1287-1292.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 1287-1292
-
-
Park, B.1
Arthington-Skaggs, B.2
Hajjeh, R.3
Iqbal, N.4
Ciblak, M.5
Lee-Yang, W.6
Hairston, M.7
Phelan, M.8
Plikaytis, B.9
Sofair, A.10
Harrison, L.11
Fridkin, S.12
Warnock, D.13
-
26
-
-
34147161053
-
Amphotericin B covalent dimers with carbonyl-amino linkage: A new probe for investigating ion channel assemblies
-
Umegawaa Y, Matsumori N, Oishia T, Murata M. 2007. Amphotericin B covalent dimers with carbonyl-amino linkage: A new probe for investigating ion channel assemblies. Tetrahedron Lett 48:3393-3396.
-
(2007)
Tetrahedron Lett
, vol.48
, pp. 3393-3396
-
-
Umegawaa, Y.1
Matsumori, N.2
Oishia, T.3
Murata, M.4
-
27
-
-
67349131909
-
Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics
-
Jung SH, Lim DH, Jung SH, Lee JE, Jeong KS, Seong H, Shin BC. 2009. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. Eur J Pharm Sci 37:313-320.
-
(2009)
Eur J Pharm Sci
, vol.37
, pp. 313-320
-
-
Jung, S.1
Lim, D.2
Jung, S.3
Lee, J.4
Jeong, K.5
Seong, H.6
Shin, B.7
-
29
-
-
0030200977
-
The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation
-
French DL, Edwards DA, Niven RW. 1996. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J Aerosol Sci 27:769-783.
-
(1996)
J Aerosol Sci
, vol.27
, pp. 769-783
-
-
French, D.1
Edwards, D.2
Niven, R.3
-
30
-
-
10744227569
-
Large porous particles for pulmonary drug delivery
-
Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. 1997. Large porous particles for pulmonary drug delivery. Science 276:1868-1872.
-
(1997)
Science
, vol.276
, pp. 1868-1872
-
-
Edwards, D.1
Hanes, J.2
Caponetti, G.3
Hrkach, J.4
Ben-Jebria, A.5
Eskew, M.6
Mintzes, J.7
Deaver, D.8
Lotan, N.9
Langer, R.10
|